Association of MTHFR C677T and A1298C polymorphisms with non-Hodgkin lymphoma susceptibility: Evidence from a meta-analysis

Scientific Reports

Volumn 4, Issue , 2014, Pages

  He, Jing ^a   Liao, Xiao Yu ^a   Zhu, Jin Hong ^b   Xue, Wen Qiong ^a   Shen, Guo Ping ^c   Huang, Shao Yi ^a   Chen, Wei ^c   Jia, Wei Hua ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MTHFR PROTEIN, HUMAN;

ALLELE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; META ANALYSIS; NONHODGKIN LYMPHOMA; PUBLISHING; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; GENE EXPRESSION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LYMPHOMA, NON-HODGKIN; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RISK; RNA, MESSENGER;

EID: 84906706005     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06159     Document Type: Article

References (58)

1. Jemal, A. et al. Global cancer statistics. CA Cancer J Clin 61, 69-90 (2011).
2. Harris, N. L. et al. The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November, 1997. Hematol J 1, 53-66 (2000).
3. Tan, D. E. et al.Genome-wide association study of B cell non-Hodgkin lymphoma identifies 3q27 as a susceptibility locus in the Chinese population. Nat Genet 45, 804-7 (2013).
4. Muller, A. M., Ihorst, G., Mertelsmann, R.&Engelhardt, M. Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol 84, 1-12 (2005).
5. Zheng, T. et al. Epidemiology of non-Hodgkin lymphoma in Connecticut. 1935-1988. Cancer 70, 840-9 (1992).
6. Nauss, K. M. & Newberne, P. M. Effects of dietary folate, vitamin B12 and methionine/choline deficiency on immune function. Adv Exp Med Biol 135, 63-91 (1981).
7. Blount, B. C. et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA 94, 3290-5 (1997).
8. Skibola, C. F. et al. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA 96, 12810-5 (1999).
9. Dianov, G. L. et al. Repair of uracil residues closely spaced on the opposite strands of plasmid DNA results in double-strand break and deletion formation. Mol Gen Genet 225, 448-52 (1991).
10. Duthie, S. J. & McMillan, P. Uracil misincorporation in human DNA detected using single cell gel electrophoresis. Carcinogenesis 18, 1709-14 (1997).
11. Gilbody, S., Lewis, S. & Lightfoot, T. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. Am J Epidemiol 165, 1-13 (2007).
12. Botto, L. D. & Yang, Q. 5, 10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 151, 862-77 (2000).
13. Taioli, E. et al. Meta-and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphismand colorectal cancer: aHuGE-GSEC review. Am J Epidemiol 170, 1207-21 (2009).
14. Gonzalez Ordonez, A. J. et al. Normal frequencies of the C677T genotypes on the methylenetetrahydrofolate reductase (MTHFR) gene among lymphoproliferative disorders but not in multiple myeloma. Leuk Lymphoma 39, 607-12 (2000).
15. Matsuo, K. et al. Association between polymorphisms of folate-and methioninemetabolizing enzymes and susceptibility to malignant lymphoma. Blood 97, 3205-9 (2001).
16. Lincz, L. F. et al. Methionine synthase genetic polymorphism MS A2756G alters susceptibility to follicular but not diffuse large B-cell non-Hodgkin's lymphoma or multiple myeloma. Br J Haematol 120, 1051-4 (2003).
17. Toffoli, G. et al.Methylenetetrahydrofolate reductase genotype in diffuse large Bcell lymphomas with and without hypermethylation of the DNA repair gene O6-methylguanine DNA methyltransferase. Int J Biol Markers 18, 218-21 (2003).
18. Gemmati, D. et al. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults. Cancer Epidemiol Biomarkers Prev 13, 787-94 (2004).
19. Linnebank, M. et al. The methionine synthase polymorphism D919G alters susceptibility to primary central nervous system lymphoma. Br J Cancer 90, 1969-71 (2004).
20. Matsuo, K. et al. Methylenetetrahydrofolate reductase gene (MTHFR) polymorphisms and reduced risk of malignant lymphoma. Am J Hematol 77, 351-7 (2004).
21. Rudd, M. F. et al. MTHFR polymorphisms and risk of chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev 13, 2268-70 (2004).
22. Skibola, C. F. et al. Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood 104, 2155-62 (2004).
23. Lightfoot, T. J. et al. Risk of non-Hodgkin lymphoma associated with polymorphisms in folate-metabolizing genes. Cancer Epidemiol Biomarkers Prev 14, 2999-3003 (2005).
24. Stanulla, M. et al. Methylenetetrahydrofolate reductase (MTHFR) 677C. T polymorphism and risk of pediatric non-Hodgkin lymphoma in a German study population. Blood 105, 906-7 (2005).
25. Niclot, S. et al. Implication of the folate-methionine metabolism pathways in susceptibility to follicular lymphomas. Blood 108, 278-85 (2006).
26. Seidemann, K. et al. MTHFR 677 (C-. T) polymorphism is not relevant for prognosis or therapy-associated toxicity in pediatric NHL: results from 484 patients of multicenter trial NHL-BFM 95. Ann Hematol 85, 291-300 (2006).
27. Timuragaoglu, A., Dizlek, S., Uysalgil, N., Tosun, O. & Yamac, K. Methylenetetrahydrofolate reductase C677T polymorphism in adult patients with lymphoproliferative disorders and its effect on chemotherapy. Ann Hematol 85, 863-8 (2006).
28. Lee, K. M. et al. One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia. Hum Genet 122, 525-33 (2007).
29. Lim, U. et al. Gene-nutrient interactions among determinants of folate and onecarbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER casecontrol study. Blood 109, 3050-9 (2007).
30. Siraj, A. K. et al. Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East. Ann Hematol 86, 887-95 (2007).
31. Gra, O. A. et al. Polymorphisms in xenobiotic-metabolizing genes and the risk of chronic lymphocytic leukemia and non-Hodgkin's lymphoma in adult Russian patients. Am J Hematol 83, 279-87 (2008).
32. Kim, H. N. et al.Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma. Br J Haematol 140, 287-94 (2008).
33. Berglund, M., Enblad, G., Turesson, I., Edman, V. & Thunberg, U. Folatemetabolizing genes in lymphoma patients from Sweden. Scand J Immunol 70, 408-10 (2009).
34. Ismail, S. I., Ababneh, N. A., Khader, Y., Abu-Khader, A. A. & Awidi, A. Methylenetetrahydrofolate reductase genotype association with the risk of follicular lymphoma. Cancer Genet Cytogenet 195, 120-4 (2009).
35. Wang, S. S., Carreon, J. D., Hanchard, B., Chanock, S. & Hisada, M. Common genetic variants and risk for non-Hodgkin lymphoma and adult T-cell lymphoma/leukemia in Jamaica. Int J Cancer 125, 1479-82 (2009).
36. Kurzwelly, D. et al. Genetic variants of folate and methionine metabolism and PCNSL incidence in a German patient population. J Neurooncol 100, 187-92 (2010).
37. Weiner, A. S. et al. Polymorphisms in folate-metabolizing genes and risk of non-Hodgkin's lymphoma. Leuk Res 35, 508-15 (2011).
38. Nasr, A. S., Sami, R. M. & Ibrahim, N. Y. Methylenetetrahydrofolate reductase gene polymorphisms (677C. T and 1298A. C) in Egyptian patients with non-Hodgkin lymphoma. J Cancer Res Ther 8, 355-60 (2012).
39. Li, Q. et al. Role of one-carbon metabolizing pathway genes and gene-nutrient interaction in the risk of non-Hodgkin lymphoma. Cancer Causes Control 24, 1875-84 (2013).
40. Gemmati, D. et al.Methylenetetrahydrofolate reductase C677T and A1298C gene variants in adult non-Hodgkin's lymphoma patients: association with toxicity and survival. Haematologica 92, 478-85 (2007).
41. Avivi, I., Zuckerman, T., Krivoy, N.&Efrati, E. Genetic polymorphisms predicting methotrexate blood levels and toxicity in adult non-Hodgkin lymphoma. Leuk Lymphoma 55, 565-70 (2014).
42. D'Angelo, V. et al. Influence of methylenetetrahydrofolate reductase gene polymorphisms on the outcome of pediatric patients with non-Hodgkin lymphoma treated with high-dose methotrexate. Leuk Lymphoma 54, 2639-44 (2013).
43. Stolzenberg-Solomon, R. Z. et al. Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers. J Natl Cancer Inst 91, 535-41 (1999).
44. Friso, S. et al. A common mutation in the 5, 10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA 99, 5606-11 (2002).
45. Frosst, P. et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10, 111-3 (1995).
46. van der Put, N. M. et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neuraltube defects? Am J Hum Genet 62, 1044-51 (1998).
47. Crott, J. W., Mashiyama, S. T., Ames, B. N. & Fenech, M. F. Methylenetetrahydrofolate reductase C677T polymorphism does not alter folic acid deficiency-induced uracil incorporation into primary human lymphocyte DNA in vitro. Carcinogenesis 22, 1019-25 (2001).
48. Rohrmann, S. et al. Cooking of meat and fish in Europe-results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Eur J Clin Nutr 56, 1216-30 (2002).
49. Bogen, K. T.&Keating, G. A. U. S. dietary exposures to heterocyclic amines. J Expo Anal Environ Epidemiol 11, 155-68 (2001).
50. Holm, K., Melum, E., Franke, A. & Karlsen, T. H. SNPexp-A web tool for calculating and visualizing correlation between HapMap genotypes and gene expression levels. BMC Bioinformatics 11, 600 (2010).
51. Stranger, B. E. et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 315, 848-53 (2007).
52. He, J. et al. Polymorphisms in the XPG gene and risk of gastric cancer in Chinese populations. Hum Genet 131, 1235-44 (2012).
53. He, J. et al. Associations of Lys939Gln and Ala499Val polymorphisms of the XPC gene with cancer susceptibility: ameta-analysis. Int J Cancer 133, 1765-75 (2013).
54. Thakkinstian, A. et al. Systematic review and meta-analysis of the association between complement component 3 and age-related macular degeneration: a HuGE review and meta-analysis. Am J Epidemiol 173, 1365-79 (2011).
55. DerSimonian, R. & Laird, N. Meta-analysis in clinical trials. Control Clin Trials 7, 177-88 (1986).
56. Mantel, N. & Haenszel, W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22, 719-48 (1959).
57. Begg, C. B. & Mazumdar, M. Operating characteristics of a rank correlation test for publication bias. Biometrics 50, 1088-101 (1994).
58. Egger, M., Davey Smith, G., Schneider, M. & Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629-34 (1997).